Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study
about
Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortexControlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson diseaseMilestones in clinical neurophysiology.Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson diseaseNoninvasive brain stimulation treatments for addiction and major depressionDopamine-dependent changes of cortical excitability induced by transcranial static magnetic field stimulation in Parkinson's disease.Analysis of variance in neuroreceptor ligand imaging studies.Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.Transcranial direct current stimulation for the treatment of Parkinson's diseaseTranscranial magnetic stimulation and connectivity mapping: tools for studying the neural bases of brain disorders.Combining functional imaging with brain stimulation in Parkinson's disease.Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET studyTherapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study.Non-invasive brain stimulation for Parkinson's disease: Current concepts and outlook 2015.[Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research].Treatment of Parkinson's disease by cortical stimulation.The corticostriatal and corticosubthalamic pathways: two entries, one target. So what?Imaging insights into basal ganglia function, Parkinson's disease, and dystoniaTask-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's diseaseCombined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.Levodopa increases memory encoding and dopamine release in the striatum in the elderly.Characteristics of the sequence effect in Parkinson's diseaseProbing the frontostriatal loops involved in executive and limbic processing via interleaved TMS and functional MRI at two prefrontal locations: a pilot study.Noninvasive brain stimulation for Parkinson's disease and dystonia.Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.The dopaminergic basis of human behaviors: A review of molecular imaging studies.Copper and copper proteins in Parkinson's disease.Transcranial magnetic stimulation at the interface with other techniques: a powerful tool for studying the human cortex.Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging.Striatal Dopamine and the Interface between Motivation and CognitionDo studies on cortical plasticity provide a rationale for using non-invasive brain stimulation as a treatment for Parkinson's disease patients?Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson's disease: A quantitative review of the literature.The heart side of brain neuromodulation.Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls.Fronto-striatal connections in the human brain: a probabilistic diffusion tractography study.Spatial remapping of cortico-striatal connectivity in Parkinson's disease.
P2860
Q26865819-AF5277DD-0624-4838-960A-8701E27C0D8FQ28475974-E2277B84-EFBD-42C9-9F3A-A88DB9AA63A2Q30430537-8A867D05-25EC-4D18-87C7-D6DCD827EEB8Q30468145-4B555683-1CAE-41C4-B5AC-398322FDA444Q30470467-1B099A7C-8F44-4682-87FA-78FAF5CD72BBQ31043230-72FD5631-FF19-4086-A87F-BD53782BBB73Q33849031-01BAA7FB-C201-4F36-A924-A3DFA607E52FQ33999407-2BFEF994-848D-4FB2-9D39-B25BD45590CEQ34083371-AE0BD21E-4EC4-4EAF-A52A-0EF7D01C4B0AQ34173257-19FBCEB3-B6F3-4D6D-B1BD-6F7DAA06B6A7Q34179187-C73DEDD4-293D-4836-B063-3DC95257AA59Q34243081-0F642BB5-65E5-4844-A211-0C922E6A9D01Q34258312-A3244AA6-7F5A-4A1E-97FE-962031393ECCQ34258319-D3C42F5F-07D1-4197-82D7-A06B63AC1266Q34258335-F3519625-4D56-4AB3-8F17-6088F9E0D716Q34495843-082A1742-6084-4035-B8AF-EE9BD8DDE00CQ34976531-DC719AD4-1B77-492A-8212-93044950AE7AQ35015442-1D73959B-631A-4E69-8714-05AB5C5B5831Q35146020-9475E161-A10F-4D57-8ED8-D0113575CD46Q35193033-6E2C968C-BC59-4423-AF4B-64E8FECE519AQ35269971-6BA69954-0B30-4AED-9AF6-568EFD498395Q35680233-16483407-8E47-49E0-ADD7-1446E97F054FQ36553302-65223F63-9D2C-4E9D-BFB6-5631B54D6028Q36571098-47311E08-3C35-406C-BF7E-759D745C547DQ36663013-2BF93293-66C3-4D25-9024-1D6E5D4AFD96Q36997368-373E2D90-A543-40D1-B305-A4D843ACC774Q37131286-11441254-A959-47C5-ABF8-80AA9923A084Q37385099-E15B3449-8522-495D-AB83-3F37B1E9F9E3Q37500893-BC2CEFCA-45BE-4C11-9654-6485C65980AAQ37616391-96CA5162-D083-41B2-8864-2B40806AC686Q37839540-DCED4D88-FC7F-4FEE-84E7-C667936BBA02Q37871233-6EB42C15-B63E-4BFB-ADFF-9F2AE06FD91EQ37909949-36F076F2-7432-4AAF-B022-C3BD15DA0686Q38162220-89DF6E40-813D-4E95-AA7B-A8497A324CABQ38209988-A8B64C05-E3F7-4E7E-BB2B-6F4BF96B984CQ38383080-23ACF01C-79E1-43D0-A853-10BBE42ED71AQ38798206-C0CE9929-08B5-4AE0-B97B-4152BA4CF7CBQ41527108-CE603D00-1469-4FF8-9D89-98C18920EFDDQ42366582-20794441-252D-48E5-B9C5-6B55CC685923Q43285295-92DD1675-EED5-4D86-B0D7-942D002AAFAE
P2860
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@ast
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@en
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@nl
type
label
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@ast
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@en
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@nl
prefLabel
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@ast
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@en
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@nl
P2860
P50
P1476
Corticostriatal functional int ...... rTMS/[11C]raclopride PET study
@en
P2093
Maria Fraraccio
Oury Monchi
P2860
P304
P356
10.1111/J.1460-9568.2005.04476.X
P407
P577
2005-12-01T00:00:00Z